LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

Strona główna・Stock List・Danaher Corp
Search

Danaher Corp

Closed

SectorHealthcare

161.94 -1.59

Strong Buy

Price update 15 maj 2026, 19:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

160.93

Max

165.5

Key metrics

By Trading Economics

Income

-168M

1B

Sales

-887M

6B

P/E

Sector Avg

32.334

51.415

EPS

2.06

Dividend yield

0.79

Profit margin

17.291

Employees

58,000

EBITDA

-514M

1.5B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+40.03% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.79%

2.34%

Next Earnings

21 lip 2026

Next Dividend date

31 lip 2026

Next Ex Dividend date

26 cze 2026

Market Stats

By TradingEconomics

Market Cap

-20B

118B

Previous open

163.53

Previous close

161.94

News Sentiment

By Acuity

55%

45%

280 / 345 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

189.8851 / 196.5 Support & Resistance

Danaher Corp Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

21 kwi 2026, 11:36 UTC

Earnings

Danaher Lifts Full-Year Forecast on Biotech, Life Sciences Gains -- Update

DJ

Read

21 kwi 2026, 11:00 UTC

Earnings

Danaher Raises Adjusted Earnings Guidance, 1Q Revenue, Profit Rise

DJ

Read

21 kwi 2026, 10:06 UTC

Earnings

Danaher 1Q Adjsuted Core Revenue Rose 0.5% >DHR

DJ

Read

21 kwi 2026, 10:05 UTC

Earnings

Danaher Sees 2Q Adjsuted Core Revenue Up Low-Single Digits >DHR

DJ

Read

21 kwi 2026, 10:05 UTC

Earnings

Danaher Still Sees 2026 Adjsuted Core Revenue Up 3%-6% >DHR

DJ

Read

21 kwi 2026, 10:05 UTC

Earnings

Danaher Had Seen 2026 Adjusted EPS $8.35-$8.50 >DHR

DJ

Read

21 kwi 2026, 10:04 UTC

Earnings

Danaher Raises 2026 View To Adj EPS $8.35-Adj EPS $8.55 >DHR

DJ

Read

21 kwi 2026, 10:04 UTC

Earnings

Danaher 1Q Operating Cash Flow $1.3B, Adjusted Free Cash Flow $1.1B >DHR

DJ

Read

21 kwi 2026, 10:00 UTC

Earnings

Danaher 1Q Cont Ops EPS $1.45 >DHR

DJ

Read

21 kwi 2026, 10:00 UTC

Earnings

Danaher 1Q Adj EPS $2.06 >DHR

DJ

Read

21 kwi 2026, 10:00 UTC

Earnings

Danaher 1Q Sales $5.95B >DHR

DJ

Read

21 kwi 2026, 10:00 UTC

Earnings

Danaher 1Q EPS $1.45 >DHR

DJ

Read

21 kwi 2026, 10:00 UTC

Earnings

Danaher 1Q Net $1.03B >DHR

DJ

Read

17 kwi 2026, 19:15 UTC

Market Talk

Danaher Seen Rebounding in 2H After Tools-Sector Weakness -- Market Talk

DJ

Read

17 kwi 2026, 19:07 UTC

Market Talk

Danaher Faces Tough Comparative but Long‑Term Story Intact -- Market Talk

DJ

Read

17 lut 2026, 20:06 UTC

Acquisitions, Mergers, Takeovers

This Medical-Devices Stock Is Soaring. Danaher Is Buying the Company. -- Barrons.com

DJ

Read

17 lut 2026, 15:14 UTC

Acquisitions, Mergers, Takeovers

Masimo Stock on Pace for Record Gains After Danaher Strikes Deal -- WSJ

DJ

Read

17 lut 2026, 14:39 UTC

Acquisitions, Mergers, Takeovers

This Medical-Devices Stock Is Soaring. It's Being Bought by Danaher. -- Barrons.com

DJ

Read

17 lut 2026, 13:30 UTC

Acquisitions, Mergers, Takeovers

This Medical-Devices Stock Is Soaring. It's Being Bought by Danaher. -- Barrons.com

DJ

Read

17 lut 2026, 13:15 UTC

Acquisitions, Mergers, Takeovers

Danaher Strikes $10 Billion Deal for Masimo -- Update

DJ

Read

17 lut 2026, 13:03 UTC

Acquisitions, Mergers, Takeovers

Danaher To Fund Masimo Acquisition With Cash on Hand, Debt Financing >DHR

DJ

Read

17 lut 2026, 13:03 UTC

Acquisitions, Mergers, Takeovers

Danaher Sees More Than $125M Annual Cost Synergies, More Than $50M Annual Revenue Synergies by Fifth Full Year >DHR MASI

DJ

Read

17 lut 2026, 13:02 UTC

Acquisitions, Mergers, Takeovers

Danaher Sees Masimo Deal Adding About 70c to Adjusted EPS in Fifth Full Year >DHR MASI

DJ

Read

17 lut 2026, 13:02 UTC

Acquisitions, Mergers, Takeovers

Danaher Sees Masimo Deal Adding 15c-20c to Adjusted EPS in First Full Year >DHR MASI

DJ

Read

17 lut 2026, 13:02 UTC

Acquisitions, Mergers, Takeovers

Masimo To Be Acquired By Danaher For $180.00 Per Share >MASI DHR

DJ

Read

17 lut 2026, 13:01 UTC

Acquisitions, Mergers, Takeovers

Danaher to Buy Masimo for Total Enterprise Value of About $9.9 Billion >DHR MASI

DJ

Read

17 lut 2026, 13:00 UTC

Acquisitions, Mergers, Takeovers

Danaher to Buy Masimo for $180/Share >DHR MASI

DJ

Read

17 lut 2026, 13:00 UTC

Acquisitions, Mergers, Takeovers

Danaher To Acquire Masimo Corporation >DHR MASI

DJ

Read

17 lut 2026, 11:09 UTC

Acquisitions, Mergers, Takeovers

Danaher Strikes $10 Billion Deal for Masimo -- WSJ

DJ

Read

17 lut 2026, 11:09 UTC

Acquisitions, Mergers, Takeovers

Danaher Acquisition of Masimo Set to Be Announced Tuesday, Sources Say -- WSJ

DJ

Read

Peer Comparison

Price change

Danaher Corp Forecast

Price Target

By TipRanks

40.03% upside

12 Months Forecast

Average 230.4 USD  40.03%

High 270 USD

Low 184.04 USD

Based on 16 Wall Street analysts offering 12 month price targets forDanaher Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

16 ratings

14

Buy

2

Hold

0

Sell

Based on 16 analysts giving stock ratings to Danaher Corp - Dist in the past 3 months.

Technical Score

By Trading Central

189.8851 / 196.5Support & Resistance

Short Term

Bullish Evidence

Recent bullish events outweigh bearish events.

Intermediate Term

Weak Bullish Evidence

There is one bullish event.

Long Term

Neutral Evidence

The bullish and bearish events are balanced.

Sentiment

By Acuity

280 / 345 Ranking in Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Danaher Corp

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company has a research collaboration with Stanford University's Department of Bioengineering for cancer drug development. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Other stocks from the sector

LLY

Eli Lilly and Co.

1,004

↓-0.33%

JNJ

Johnson and Johnson

226.76

↓-1.74%

ABBV

AbbVie Inc

210.42

↓-0.19%

UNH

UnitedHealth Group Inc

393.66

↓-1.34%

AZN

AstraZeneca PLC

181.62

↓-1.79%
help-icon Live chat